Table 3.
Compound | % survival (no. surviving/total no.) |
|
---|---|---|
Day 5 | Day 12 | |
Uninfected control | 81 (18/22) | 45 (10/22) |
Infected control | 14 (6/42) | 12 (5/42) |
Vancomycin | 94 (32/34) | 15 (5/34) |
Amixicile | 56 (23/42) | 56 (23/42) |
Nitazoxanide | 22 (7/32) | 22 (7/32) |
Fidaxomicin | 80 (8/10) | 20 (2/10) |